Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.